Cysteine protease inhibitor E64d is reported to have protective effects for brain injury and Alzheimer’s disease (Kuwako et al, 2002; Tsubokawa et al, 2006a, 2006b; Hook et al, 2014) and proved to be safe for use in humans. The gene discussed is CTSB; the disease is early-onset autosomal dominant Alzheimer disease.